Viewing Study NCT00476203


Ignite Creation Date: 2025-12-24 @ 7:35 PM
Ignite Modification Date: 2026-01-06 @ 9:59 AM
Study NCT ID: NCT00476203
Status: COMPLETED
Last Update Posted: 2012-11-28
First Post: 2007-05-17
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Yoga Study in Breast Cancer Patients
Sponsor: Fred Hutchinson Cancer Center
Organization:

Study Overview

Official Title: Effect of Yoga on Weight and Fatigue in Breast Cancer Patients Study
Status: COMPLETED
Status Verified Date: 2012-11
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: Yoga
Brief Summary: This purpose of this study is to test whether a 6-month yoga program improves quality of life and reduces fatigue and weight gain in breast cancer survivors.
Detailed Description: Women who are overweight or obese have a higher risk of breast cancer than normal weight women. Furthermore, women who are overweight or obese or gain weight after diagnosis have an increased risk of recurrence or dying from breast cancer compared with normal weight women. Yoga has been associated with reduced weight gain and weight loss in persons without cancer. However, no studies have tested whether yoga leads to less weight gain or weight loss in breast cancer patients. Both obesity and the sequelae of breast cancer therapy can result in reduced health-related quality of life and severe fatigue, which may also be favorably affected by yoga practice. The specific aims of the proposed trial are to examine, in women with Stage 0-IIIa breast cancer who are at least 3 months post primary treatment for their disease (other than tamoxifen or aromatase inhibitors), the effects of a 6-month yoga intervention on health-related quality of life, fatigue, and body weight.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
U54CA116847-01 NIH None https://reporter.nih.gov/quic… View